BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

629 related articles for article (PubMed ID: 28871458)

  • 1. Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatment.
    Lin M; Liang S; Wang X; Liang Y; Zhang M; Chen J; Niu L; Xu K
    J Cancer Res Clin Oncol; 2017 Dec; 143(12):2607-2618. PubMed ID: 28871458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An important discovery on combination of irreversible electroporation and allogeneic natural killer cell immunotherapy for unresectable pancreatic cancer.
    Lin M; Alnaggar M; Liang S; Wang X; Liang Y; Zhang M; Chen J; Niu L; Xu K
    Oncotarget; 2017 Nov; 8(60):101795-101807. PubMed ID: 29254205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term clinical efficacy of percutaneous irreversible electroporation combined with allogeneic natural killer cell for treating metastatic pancreatic cancer.
    Lin M; Liang S; Wang X; Liang Y; Zhang M; Chen J; Niu L; Xu K
    Immunol Lett; 2017 Jun; 186():20-27. PubMed ID: 28392199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of irreversible electroporation ablation combined with natural killer cells in treating locally advanced pancreatic cancer.
    Pan Q; Hu C; Fan Y; Wang Y; Li R; Hu X
    J BUON; 2020; 25(3):1643-1649. PubMed ID: 32862617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Short-Term Efficacy of Irreversible Electroporation and Allogenic Natural Killer Cell Immunotherapy Combination in the Treatment of Patients with Unresectable Primary Liver Cancer.
    Yang Y; Qin Z; Du D; Wu Y; Qiu S; Mu F; Xu K; Chen J
    Cardiovasc Intervent Radiol; 2019 Jan; 42(1):48-59. PubMed ID: 30151798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogenic Natural Killer Cell Immunotherapy Combined with Irreversible Electroporation for Stage IV Hepatocellular Carcinoma: Survival Outcome.
    Alnaggar M; Lin M; Mesmar A; Liang S; Qaid A; Xu K; Chen J; Niu L; Yin Z
    Cell Physiol Biochem; 2018; 48(5):1882-1893. PubMed ID: 30092590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ablation of Locally Advanced Pancreatic Cancer with Percutaneous Irreversible Electroporation: Results of the Phase I/II PANFIRE Study.
    Scheffer HJ; Vroomen LG; de Jong MC; Melenhorst MC; Zonderhuis BM; Daams F; Vogel JA; Besselink MG; van Kuijk C; Witvliet J; de van der Schueren MA; de Gruijl TD; Stam AG; van den Tol PM; van Delft F; Kazemier G; Meijerink MR
    Radiology; 2017 Feb; 282(2):585-597. PubMed ID: 27604035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous Irreversible Electroporation in Locally Advanced and Recurrent Pancreatic Cancer (PANFIRE-2): A Multicenter, Prospective, Single-Arm, Phase II Study.
    Ruarus AH; Vroomen LGPH; Geboers B; van Veldhuisen E; Puijk RS; Nieuwenhuizen S; Besselink MG; Zonderhuis BM; Kazemier G; de Gruijl TD; van Lienden KP; de Vries JJJ; Scheffer HJ; Meijerink MR
    Radiology; 2020 Jan; 294(1):212-220. PubMed ID: 31687922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival.
    Martin RC; McFarland K; Ellis S; Velanovich V
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S443-9. PubMed ID: 23128941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy.
    Martin RC; Kwon D; Chalikonda S; Sellers M; Kotz E; Scoggins C; McMasters KM; Watkins K
    Ann Surg; 2015 Sep; 262(3):486-94; discussion 492-4. PubMed ID: 26258317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryoablation combined with allogenic natural killer cell immunotherapy improves the curative effect in patients with advanced hepatocellular cancer.
    Lin M; Liang S; Wang X; Liang Y; Zhang M; Chen J; Niu L; Xu K
    Oncotarget; 2017 Oct; 8(47):81967-81977. PubMed ID: 29137237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irreversible electroporation versus radiotherapy after induction chemotherapy on survival in patients with locally advanced pancreatic cancer: a propensity score analysis.
    He C; Wang J; Sun S; Zhang Y; Lin X; Lao X; Cui B; Li S
    BMC Cancer; 2019 Apr; 19(1):394. PubMed ID: 31029111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial experience of irreversible electroporation for locally advanced pancreatic cancer in a Korean population.
    Kwon JH; Chung MJ; Park JY; Lee HS; Hwang HK; Kang CM; Lee WJ; Park MS; Kim N; Bang S; Kim MD
    Acta Radiol; 2021 Feb; 62(2):164-171. PubMed ID: 32295390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irreversible electroporation plus allogenic Vγ9Vδ2 T cells enhances antitumor effect for locally advanced pancreatic cancer patients.
    Lin M; Zhang X; Liang S; Luo H; Alnaggar M; Liu A; Yin Z; Chen J; Niu L; Jiang Y
    Signal Transduct Target Ther; 2020 Oct; 5(1):215. PubMed ID: 33093457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous Image-Guided Irreversible Electroporation for the Treatment of Unresectable, Locally Advanced Pancreatic Adenocarcinoma.
    Narayanan G; Hosein PJ; Beulaygue IC; Froud T; Scheffer HJ; Venkat SR; Echenique AM; Hevert EC; Livingstone AS; Rocha-Lima CM; Merchan JR; Levi JU; Yrizarry JM; Lencioni R
    J Vasc Interv Radiol; 2017 Mar; 28(3):342-348. PubMed ID: 27993507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combining intraoperative ultrasound-guided irreversible electroporation with chemotherapy for treating locally advanced pancreatic cancer: a clinical report of 64 cases].
    Li SP; He CB; Wang J; Mao YZ; Lao XM; Cui BK; Lin XJ
    Zhonghua Wai Ke Za Zhi; 2020 Oct; 58(10):787-792. PubMed ID: 32993267
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of combination therapies in the management of locally advanced pancreatic cancer: Induction chemotherapy followed by irreversible electroporation vs radiofrequency ablation.
    He C; Wang J; Zhang Y; Cai Z; Lin X; Li S
    Cancer Med; 2020 Jul; 9(13):4699-4710. PubMed ID: 32410380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-Institution Experience with Irreversible Electroporation for T4 Pancreatic Cancer: First 50 Patients.
    Kluger MD; Epelboym I; Schrope BA; Mahendraraj K; Hecht EM; Susman J; Weintraub JL; Chabot JA
    Ann Surg Oncol; 2016 May; 23(5):1736-43. PubMed ID: 26714959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of CT-Guided Percutaneous Irreversible Electroporation Added to FOLFIRINOX Chemotherapy in Locally Advanced Pancreatic Cancer: A Post Hoc Comparison.
    van Veldhuisen E; Vroomen LG; Ruarus AH; Derksen TC; Busch OR; de Jong MC; Kazemier G; Puijk RS; Sorgedrager NS; Vogel JA; Scheffer HJ; van Lienden KP; Wilmink JW; Besselink MG; Meijerink MR
    J Vasc Interv Radiol; 2020 Oct; 31(10):1600-1608. PubMed ID: 32861569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of the efficacy of irreversible electroporation and conversional resection for locally advanced pancreatic cancer].
    He CB; Wang J; Mao YZ; Lao XM; Li SP
    Zhonghua Wai Ke Za Zhi; 2022 Oct; 60(10):948-954. PubMed ID: 36207984
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 32.